A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

BACKGROUND: There is no standard first-line therapy for advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma and the prognosis remains poor. Our institution conducted a phase I study of oxaliplatin, irinotecan, and capecitabine given in a novel, weekly schedule. The regimen was tolera...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Brell, Joanna M., Krishnamurthi, Smitha S., Javle, Milind, Saltzman, Joel, Wollner, Ira, Pelley, Robert, Dowlati, Afshin, Kantharaj, Belagodu N., Schluchter, Mark D., Rath, Linda, Ivy, S. Percy, Remick, Scot C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209292/
https://ncbi.nlm.nih.gov/pubmed/18670776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-008-0807-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky